rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Thierry Bernard

Director

Company insider

Files Form 4 as: Director, Bruker; Director, Neogen; Director, T2 Biosystems.

In numbers

Trades disclosed
25
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
3
First trade
6 Aug 2020
Last trade
15 May 2026
Last filed
19 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
BRKR BrukerDirector · Life-science tools · last 15 May 20260 buys · 0 sells
NEOG NeogenDirector · Diagnostics & Labs · last 23 Oct 20250 buys · 0 sells
T2 BiosystemsDirector · last 15 Sep 20230 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 May 2026filed 19 May 2026BRKR BrukerLife-science toolsSEC FORM 4 Code A—2,886 at $0.00filing
15 May 2026filed 19 May 2026BRKR BrukerLife-science toolsSEC FORM 4 Code A—2,886 at $0.00filing
23 Oct 2025filed 27 Oct 2025NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—50,814 at $0.00filing
23 Oct 2025filed 27 Oct 2025NEOG NeogenDiagnostics & LabsSEC FORM 4 Code A$120K19,769 at $6.07filing
1 Nov 2024filed 5 Nov 2024NEOG Neogenoption or derivative · Diagnostics & LabsSEC FORM 4 Code A—17,207 at $0.00filing
1 Nov 2024filed 5 Nov 2024NEOG NeogenDiagnostics & LabsSEC FORM 4 Code A$81K5,620 at $14.44filing
15 Sep 2023filed 11 Oct 2023T2 Biosystemsoption or derivativeSEC FORM 4 Code M—2,300 at $0.00filing
15 Sep 2023filed 11 Oct 2023T2 BiosystemsSEC FORM 4 Code M—2,300filing
6 Aug 2023filed 16 Aug 2023T2 Biosystemsoption or derivativeSEC FORM 4 Code M—454 at $0.00filing
6 Aug 2023filed 16 Aug 2023T2 BiosystemsSEC FORM 4 Code M—454filing
1 Jan 2023filed 16 Aug 2023T2 Biosystemsoption or derivativeSEC FORM 4 Code M—1,550 at $0.00filing
1 Jan 2023filed 16 Aug 2023T2 BiosystemsSEC FORM 4 Code M—1,550filing
11 Oct 2022filed 13 Oct 2022T2 Biosystemsoption or derivativeSEC FORM 4 Code A—115,000 at $0.00filing
6 Aug 2022filed 9 Aug 2022T2 Biosystemsoption or derivativeSEC FORM 4 Code M—22,727 at $0.00filing
6 Aug 2022filed 9 Aug 2022T2 BiosystemsSEC FORM 4 Code M—22,727filing
25 Jun 2022filed 28 Jun 2022T2 Biosystemsoption or derivativeSEC FORM 4 Code M—73,224 at $0.00filing
25 Jun 2022filed 28 Jun 2022T2 BiosystemsSEC FORM 4 Code M—73,224filing
1 Jan 2022filed 4 Jan 2022T2 Biosystemsoption or derivativeSEC FORM 4 Code M—32,258 at $0.00filing
1 Jan 2022filed 4 Jan 2022T2 Biosystemsoption or derivativeSEC FORM 4 Code A—77,519 at $0.00filing
1 Jan 2022filed 4 Jan 2022T2 BiosystemsSEC FORM 4 Code M—32,258filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Mikheal NassifCEO · CEO at Neogen, filing Form 4 there in the last year
Rafael A. RodriguezDirector · Director at Neogen, filing Form 4 there in the last year
Avi PelossofDirector · Director at Neogen, filing Form 4 there in the last year
Ronald D. GreenDirector · Director at Neogen, filing Form 4 there in the last year
James C. BorelDirector · Director at Neogen, filing Form 4 there in the last year